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ABSTRACT
Objectives: To quantitatively assess time-series
studies of daily nitrogen dioxide (NO2) and mortality
and hospital admissions which also controlled for
particulate matter (PM) to determine whether or to
what extent the NO2 associations are independent
of PM.
Design: A systematic review and meta-analysis.
Methods: Time-series studies—published in peer-
reviewed journals worldwide, up to May 2011—that
reported both single-pollutant and two-pollutant model
estimates for NO2 and PM were ascertained from
bibliographic databases (PubMed, EMBASE and Web
of Science) and reviews. Random-effects summary
estimates were calculated globally and stratified by
different geographical regions, and effect modification
was investigated.
Outcome measures: Mortality and hospital
admissions for various cardiovascular or respiratory
diseases in different age groups in the general population.
Results: 60 eligible studies were identified, and meta-
analysis was conducted on 23 outcomes. Two-pollutant
model study estimates generally showed that the NO2
associations were independent of PM mass. For all-cause
mortality, a 10 µg/m3 increase in 24-hour NO2 was
associated with a 0.78% (95% CI 0.47% to 1.09%)
increase in the risk of death, which reduced to 0.60%
(0.33% to 0.87%) after control for PM. Heterogeneity
between geographical region-specific estimates was
removed by control for PM (I2 from 66.9% to 0%).
Estimates of PM and daily mortality assembled from the
same studies were greatly attenuated after control for
NO2: from 0.51% (0.29% to 0.74%) to 0.18% (−0.11%
to 0.47%) per 10 µg/m3 PM10 and 0.74% (0.34% to
1.14%) to 0.54% (−0.25% to 1.34%) for PM2.5.
Conclusions: The association between short-term
exposure to NO2 and adverse health outcomes is
largely independent of PM mass. Further studies
should attempt to investigate whether this is a generic
PM effect or whether it is modified by the source and
physicochemical characteristics of PM. This finding
strengthens the argument for NO2 having a causal role
in health effects.
INTRODUCTION
Outdoor air pollution has long been estab-
lished as a hazard to human health, with par-
ticulate matter (PM) regarded as the most
plausible toxicant in the mixture of ambient
air pollutants.1–5 The epidemiological evidence
has consistently shown adverse associations
between chronic and short-term exposure to
PM and mortality and morbidity from cardio-
vascular and respiratory disease, and this is sup-
ported by experimental evidence.6 While the
epidemiological evidence also shows relation-
ships between nitrogen dioxide (NO2) and
adverse health effects, concerns have been
expressed repeatedly about the causal nature
of these associations.7–11 It has been asserted
Strengths and limitations of this study
▪ This is, to date, the most comprehensive quanti-
tative systematic review of the time-series litera-
ture on nitrogen dioxide (NO2) published
worldwide to evaluate the two-pollutant model
estimates of mortality or hospital admissions
and short-term exposure to NO2 adjusted for
particulate air pollution.
▪ It reports meta-analytical estimates both globally
and for different geographical regions, as well as
provides an assessment of heterogeneity
between the region-specific estimates.
▪ The protocol-led approach to the identification of
studies and estimates for use in meta-analysis
minimised selection bias at each stage of the
review.
▪ Meta-analysis was limited to studies that pro-
vided effect estimates in numerical—rather than
graphical—form, along with sufficient quantita-
tive data to enable standardisation of estimates.
▪ Further work is needed to understand reasons
for the heterogeneity observed and to quantita-
tively assess the extent to which PM may be
associated with health independently of NO2.
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that the NO2 associations do not reﬂect adverse effects of
NO2 itself but, rather, reﬂect the health effects of other air
pollutants, mainly PM or other components of the
complex mixture of trafﬁc-related air pollutants. Primarily,
this is due to the strong correlations between NO2 and
other combustion-derived air pollutants, especially PM.
The extent of these correlations varies from city-to-city and
over time, due to variations in emission sources. Scepticism
also exists because of limited experimental evidence (con-
trolled human exposure and animal toxicology studies) for
NO2, which, to date, has focused largely on respiratory end-
points and has generally employed concentrations of NO2
well above current ambient levels.7–9 In light of the uncer-
tainties regarding NO2 and the stronger evidence for asso-
ciations between PM and health, many researchers and
policymakers have adopted a view that the epidemiological
associations of NO2 reﬂect adverse health effects of PM.
In an earlier paper, we reviewed the time-series evi-
dence associating daily concentrations of NO2 with daily
mortality and emergency hospital admissions.12 In this
study, we assess the subset of time-series studies, report-
ing all-year estimates of NO2 from both single-pollutant
and two-pollutant models adjusted for PM to determine
whether the NO2 associations are attenuated after adjust-
ment for PM.
METHODS
The full method and a priori protocols governing the
identiﬁcation of studies and effect estimates for the sys-
tematic review have been described previously,12–14 but a
synopsis, along with aspects unique to this review, is pro-
vided below.
Identification of studies for review
Three bibliographic databases were searched to identify
peer-reviewed time-series studies of NO2 and daily mor-
tality or hospital admissions indexed up to May 2011. No
restriction on language was applied. The literature
search strategy is described in the online supplementary
material, and the following inclusion criteria were used:
papers must (1) have had a minimum of 1 year of data;
(2) been based on the general population; (3) have con-
trolled for important confounding factors, including
season and meteorological factors; and (4) have
reported sufﬁcient quantitative information, in numeric
format, to enable the calculation of standardised effect
estimates and standard errors for use in quantitative ana-
lysis. Two authors of the review—ICM and RWA—under-
took the literature search.
Data extraction and coding
Data from each relevant study were entered into a
Microsoft Access database (Microsoft Ofﬁce 2010,
Microsoft Corporation). These included:
A. Citation details of each paper;
B. All-year single-pollutant and two-pollutant model esti-
mates of NO2 adjusted for PM;
C. Single-pollutant and two-pollutant model estimates of
PM adjusted for NO2 reported in studies providing
data for NO2;
D. Season-speciﬁc estimates of NO2, including those
adjusted for PM, from studies reporting all-year
estimates;
E. Descriptive (outcome, diagnosis (International
Classiﬁcation of Diseases codes), age, etc) and quan-
titative data (pollution increment and averaging time
etc) associated with each estimate, and needed for
calculating standardised estimates expressed as the
percentage change (and 95% CI) in the mean
number of daily events associated with a 10 µg/m3
increase in NO2 (or PM);
F. Correlations between concentrations of NO2 and
PM;
G. Effect modiﬁers for investigating of sources of het-
erogeneity in all-year estimates.
Time-series studies often report results for different
time lags (in days) between exposure and health events,
and they vary in the lag for the reported results. We
identiﬁed, for each outcome/disease/age/averaging
time combination from each study, a pair of estimates of
NO2, that is from a single-pollutant model and a corre-
sponding estimate adjusted for PM for the same lag, to
enable comparison of the NO2 association before and
after adjustment for PM. To avoid selection bias, we
developed an a priori protocol for identifying the princi-
pal lag for each outcome/disease/age/averaging time
combination for use in our review. This was the lag high-
lighted by the author or stated a priori, and if this was
not clear, because several lagged model estimates were
reported, we chose (1) the lag with the highest statistical
signiﬁcance, regardless of the estimate being positive or
negative, or (2) the lag with the largest estimate, again,
irrespective of its direction. If only results from cumula-
tive or distributed lag models—that is, lags averaged over
several days—were reported in a study, these were used.
In some instances, a different lag was investigated in two-
pollutant models. In such cases, the lagged estimate
from the two-pollutant model was coded according to
the same algorithm and the (additional) corresponding
single-pollutant estimate for the same lag was coded in
our database.
Processing of data also included classifying each study
into the geographical region, as the WHO region, in
which the study was conducted, as well as categorising
the various metrics of PM controlled for in two-pollutant
models: see online supplementary material for details.
Statistical analyses
A similar procedure to that outlined in our earlier paper
was used for meta-analysis,12 but with some modiﬁca-
tions, in order to identify a pair of estimates of NO2 for
each pollutant/outcome combination from each study.
We applied an a priori protocol to select estimates for
meta-analysis to avoid selection bias and duplication of
studies from the same population. We gave priority to
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estimates from multicity studies over estimates from
single-city studies and the results from any one city
appeared only once in a meta-analysis. If results from
more than one multicity study within a WHO region were
available, we selected, in order of priority, the multicity
estimate from the study: (1) with the most cities/greatest
geographical coverage; (2) the most recently published;
(3) the most recent study time period. If a multicity study
did not report a summary estimate across the cities exam-
ined, for analysis, we treated estimates from these studies
in the same manner as estimates from single-city studies.
We selected estimates from single-city studies only if they
did not appear in multicity studies. For cities not
included in a multicity study summary result, we selected,
in order of priority: (1) the most recently published, or
(2) the most recent study time period.
Meta-analysis was conducted when ≥4 estimates were
available for an outcome/disease/age/averaging time
combination—including where a multicity estimate was
available—and summary estimates were calculated using
a random-effects model.15 We used a staged approach to
meta-analysis, with single-city estimates pooled within
WHO region prior to the pooled single-city and selected
multicity estimates being pooled to produce a global esti-
mate and WHO region-speciﬁc summary estimates.
Heterogeneity between WHO region summary estimates
was assessed using the I2 statistic,16 with I2 statistics >50%
regarded as being evidence of high heterogeneity.17
Meta-analysis was undertaken for:
A. Single-pollutant NO2 estimates relating to two-
pollutant models;
B. Corresponding NO2 estimates adjusted for any PM
metric:
i. if within a study, several estimates of NO2 adjusted
for different individual PM metrics were available,
a NO2 estimate was selected according to the fol-
lowing order of priority of PM metric used in
adjustment: PM10, PM2.5, Black Smoke, PM10−2.5;
ii. if, having applied the protocol, a NO2 estimate was
not selected for a city because several were avail-
able due to different PM metrics used to adjust the
NO2 effect in different studies, the NO2 estimate
was chosen in the order of priority of the PM
metrics listed above.
C. We conducted additional meta-analyses for NO2
adjusted for speciﬁc metrics of particles, for
example, NO2 adjusted for PM10 and separately for
PM2.5, and so on, to determine whether the NO2
associations showed different sensitivity to control for
different PM metrics.
All analyses were conducted in STATA (STATA/SE
V.11. StataCorp, Texas, USA).
RESULTS
Sixty studies provided estimates of both (1) NO2, single-
pollutant, and (2) NO2 adjusted for PM: a list of refer-
ences is provided in the online supplementary material.
Table 1 presents a summary of these 60 time-series
studies stratiﬁed by the PM metric controlled for in
regression models, broad disease categories, WHO
regions in which the studies were conducted, single-city
and multicity study designs, and by averaging time
(24-hour and 1 hour).
There were 36 and 24 studies of daily mortality or hos-
pital admissions, respectively, and 13 studies used a mul-
ticity design. The majority of the studies were conducted
in the WHO regions European A and Western Paciﬁc
region B, and most used 24-hour NO2. Forty of the 60
studies controlled for the effects of daily PM10 in the
regression models for NO2, and a much smaller number
of studies used other particle size fractions or constitu-
ents of PM. Eight studies of mortality and two of hospital
admissions reported estimates of NO2, each adjusted for
a different PM metric. None of the studies investigated
the inﬂuence of carbon on the NO2 associations, and
four studies controlled for the effects of ultraﬁne
particles.
NO2 and all-cause mortality
Figure 1 shows all available (32 pairs) single-pollutant
and two-pollutant estimates for 24-hour NO2 and daily
all-cause mortality in all ages. In the majority of studies,
daily NO2 was positively and signiﬁcantly associated with
increases in the risk of death, including after controlling
for daily PM. In many of the studies, the NO2 estimates
were not greatly reduced in size, changed direction or
lose statistical signiﬁcance after adjustment for PM. In
general, the NO2 estimates appeared robust to adjust-
ment for PM at both high and low correlations between
concentrations of NO2 and PM.
Fifteen (of 32) pairs of estimates for 24-hour NO2 and
all-cause mortality, which represented 26 cities from ﬁve
WHO regions, were selected for meta-analysis (see
online supplementary ﬁgure S1). The random-effects
single-pollutant summary estimate for all-cause mortality
was 0.78% (95% CI 0.47% to 1.09%) per 10 µg/m3
increase in NO2. There was evidence of high heterogen-
eity (I2=66.9%) between the WHO region-speciﬁc esti-
mates, which ranged from 0.48% for WHO region
America A to 1.41% for South East Asia B (see online
supplementary table S1). The overall estimate was com-
parable to the single-pollutant summary estimate of
0.71% (95% CI 0.43% to 1.00%) calculated from the
larger body of time-series evidence analysed in our previ-
ous paper.12 After adjustment for daily PM, all-cause
mortality remained positively and signiﬁcantly associated
with 24-hour NO2: 0.60% (95% CI 0.33% to 0.87%) per
10 µg/m3 increase in NO2, and there was no evidence of
heterogeneity (I2=0%) between the region-speciﬁc
estimates.
Control for speciﬁc PM metrics did not greatly alter
the relationship of 24-hour NO2 with all-cause mortality
(table 2). With the exception of NO2 adjusted for PM10,
and to a lesser extent PM2.5, meta-analyses for NO2
adjusted for the remaining PM metrics were limited to
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ﬁndings from a multicity Canadian study by Burnett
et al18—see ﬁgure 1.
Six pairs of estimates were available for meta-analysis
for all-cause mortality and 1 hour NO2 adjusted for
PM (see online supplementary ﬁgure S2). Thirty of
the 36 cities represented by these estimates were in
Europe. Meta-analysis of four pairs of estimates
resulted in an overall estimate of 0.32% (95% CI
−0.02% to 0.66%) for a 10 µg/m3 increment in 1 hour
NO2 and 0.20% (95% CI −0.24% to 0.65%) following
adjustment for PM (see online supplementary table
S2). High heterogeneity was observed between the
WHO region-speciﬁc estimates. In contrast with ﬁnd-
ings for 24-hour measures, the summary estimate for
1 hour NO2 for WHO region European A was little
affected by adjustment for PM10 (or Black Smoke)—
see online supplementary table S2. Table 3 provides
meta-analysis results for all-cause mortality and 1 hour
NO2 adjusted for different PM metrics. Control for
PM10 led to attenuation of the estimate and loss of
statistical signiﬁcance, while the association was robust
to control for Black Smoke and visibility (measured as
black suspended particles, BSP).
NO2 and mortality from specific causes
NO2 estimates adjusted for PM were available for several
speciﬁc causes of death in all ages: all cardiovascular
(see online supplementary ﬁgures S3 and S4), all
respiratory (see online supplementary ﬁgure S5), stroke
(see online supplementary ﬁgure S6), cardiac (see
online supplementary ﬁgure S7), ischaemic heart
disease, dysrhythmia, chronic obstructive pulmonary
disease including asthma and lower respiratory infec-
tions (see online supplementary ﬁgure S8). Sufﬁcient
numbers of estimates for meta-analysis were available for
all cardiovascular (see online supplementary table S3),
all respiratory (see online supplementary table S4) and
stroke (see online supplementary table S5) mortality.
Eight studies providing 14 pairs of estimates showed
positive associations between all cardiovascular deaths
and 24-hour NO2, including after adjustment mainly for
PM10 (see online supplementary ﬁgure S3). However,
Table 1 Summary of time-series studies of daily mortality or hospital admissions and NO2 adjusted for PM
Total Multicity study Single-city study
Outcome Mortality
Hospital
admissions Mortality
Hospital
admissions Mortality
Hospital
admissions
Total 36 24 9 4 27 20
NO2+PM*
PM10 23 17 6 2 17 15
PM2.5 7 1 3 1 4 0
PM10–2.5 4 0 3 0 1 0
BS 5 4 3 2 2 2
PNC 3 1 0 0 3 1
Carbon 0 0 0 0 0 0
TSP 4 2 0 1 4 1
Visibility 2 1 2 1 0 0
>1 PM metric 0 1 0 0 0 1
Disease†
All-cause 27 1 7 0 20 1
Cardiovascular 17 11 4 2 13 9
Respiratory 7 17 3 3 4 14
WHO region‡
American A 8 4 3 0 5 4
European A 9 12 3 2 6 10
Western Pacific B 14 5 2 0 12 5
American B 4 2 0 0 4 2
Western Pacific A 1 2 1 2 0 0
South East Asia B 2 0 2 0 0 0
Averaging time
24 hour 29 21 6 3 23 18
Maximum 1 hour 7 5 3 2 4 3
*The eight categories of PM metrics listed in the table above have been generated by grouping different measures of particles. PM10 and
PM2.5 refer to the mass per cubic metre of particles of generally <10 μm and 2.5 μm diameter, respectively, in the ambient air.
†Respiratory includes all-respiratory diseases, asthma, COPD, COPD including asthma, lower respiratory infections and upper respiratory
diseases; Cardiovascular includes all-cardiovascular diseases, cardiac disease, heart failure, ischaemic heart disease, dysrhythmia and
stroke.
‡WHO regions: (A) very low child and adult mortality; (B) low child mortality and low adult mortality; (C) low child mortality and high adult
mortality; (D) high child mortality and high adult mortality.
BS, Black Smoke; COPD, chronic obstructive pulmonary disease; PM, particulate matter; PNC, particle number concentration; TSP, total
suspended particles.
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attenuation of estimates and loss of statistical signiﬁ-
cance was observed in the few studies with control for
PM2.5 or Black Smoke. Meta-analysis of 10 pairs of esti-
mates found a 1.07% (95% CI 0.43% to 1.72%) increase
in the risk of death from all cardiovascular diseases per
10 µg/m3 increase in 24-hour NO2 (see online supple-
mentary table S3 and ﬁgure S9). This was attenuated
(0.82% (95% CI 0.22% to 1.42%))—see online supple-
mentary table S3—following adjustment for PM, but
comparable to our earlier result (0.88% (95% CI 0.63%
to 1.13%)).12 Control of the NO2 association with all
cardiovascular mortality for speciﬁc PM metrics showed
an association that was robust to adjustment for PM10
(table 2). There were too few estimates to permit
meta-analysis for other PM metrics controlled for in the
studies. The available data for 1 hour NO2 and all car-
diovascular mortality were sparse and limited to two
studies representing 29 European cities that showed
positive NO2 associations that were robust to adjustment
for both PM10 and Black Smoke (see table 3 and online
supplementary ﬁgure S4).
Evidence for all respiratory mortality and 24-hour NO2
adjusted for PM came from six cities (see online supple-
mentary ﬁgure S5). Meta-analysis produced a 1.42%
(95% CI 0.64% to 2.21%) increased risk of all respira-
tory deaths per 10 µg/m3 increase in 24-hour NO2 (see
online supplementary table S4 and ﬁgure S10). The cor-
responding estimate adjusted for particles was attenu-
ated (1.13% (95% CI 0.46% to 1.81%)) but was
comparable to the single-pollutant estimate (1.09%
(95% CI 0.75% to 1.42%)) derived from the larger body
of time-series evidence examined in our previous
paper.12 There was no evidence of heterogeneity
(I2=0%) between the geographic speciﬁc estimates
either before or after adjustment for PM (see online
supplementary table S4). Evidence for associations
between all respiratory mortality and 1 hour NO2 came
solely from the multicity APHEA II study of 29
European cities,19 which showed a positive association
that was robust to adjustment for PM10 but not Black
Smoke (table 3).
PM and mortality
Meta-analyses were undertaken separately for PM
adjusted for the different averaging times of NO2 to
allow comparison with the relevant meta-analyses for
NO2, using data from the same studies, cities and time
periods. Figure 2 shows positive, single-pollutant
Figure 1 All available studies providing two-pollutant model estimates for meta-analysis for all-cause mortality, all ages, 24-hour
NO2. 1000×ln (RR) approximates to a percentage change per 10 µg/m
3. *Single-pollutant model estimate for days with both NO2
and visibility (coefficient of haze, COH) data in Burnett et al,18 [RMID 3000]. NO2, single-pollutant NO2 adjusted for PM.
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Table 2 Random-effects summary estimates (as percentage change (95% CIs)) for mortality or hospital admissions associated with a 10 µg/m3 increase 24 hour average pollution
All
SC/MC*
Selected
SC/MC (cities)†
24-hour NO2 24-hour PM
Single-pollutant Adjusted for PM Single-pollutant Adjusted for NO2
All-cause mortality, all ages
PM10 13/3 4/1 (21) 0.92 (0.58 to 1.72) 0.85 (0.52 to 1.18) 0.51 (0.29 to 0.74) 0.18 (−0.11 to 0.47)
PM2.5 2/3 2/1 (14) 0.53 (0.42 to 0.64) 0.57 (0.24 to 0.89) 0.74 (0.34 to 1.14) 0.54 (−0.25 to 1.34)
PM10–2.5 0/3 0/1 (12) 0.62 (0.19 to 1.06) 0.73 (0.28 to 1.18) 0.65 (−0.10 to 1.42) 0.31 (−0.49 to 1.11)
Visibility 0/1 0/1 (12) 0.60 (0.34 to 0.87) 0.66 (0.33 to 1.00) 40.93 (23.39 to 60.97)‡ 12.42 (−4.47 to 32.29)‡
All cardiovascular mortality, all ages
PM10 10/0 4/0 (8) 0.99 (0.49 to 1.49) 0.87 (0.28 to 1.46) 0.48 (0.18 to 0.78) 0.19 (−0.21 to 0.59)
All respiratory mortality, all ages
PM10 7/0 2/0 (5) 1.44 (0.63 to 2.27) 1.15 (0.47 to 1.84) 0.58 (0.22 to 0.93) 0.13 (−0.18 to 0.44)
All respiratory hospital admissions, children (5–14 years)
PM10 0/1 0/1 (5) 5.95 (1.74 to 10.33) 6.56 (3.08 to 10.17) – –
Cardiac hospital admissions, all ages
PM10 2/1 2/1 (7) 0.93 (0.46 to 1.40) 0.75 (−0.13 to 1.64) – –
BS 0/1 0/1 (4) 0.68 (0.17 to 1.20) 0.36 (−0.65 to 1.38) – –
TSP 0/1 0/1 (6) 1.03 (0.45 to 1.61) 1.08 (0.43 to 1.72) – –
*Numbers of available pairs of single-city (SC)/multi-city (MC) estimates from all studies.
†Numbers of pairs of pooled (from single-city estimates) and multicity estimates used to calculate the overall summary estimate across WHO regions. Estimates were selected for meta-analysis
from all those available. The number of cities represented by the summary estimates is given in brackets.
‡The results for visibility (measured as coefficient of haze (COH units)) are not comparable to other PM results.
BS. Black Smoke; NO2, nitrogen dioxide; PM, particulate matter.
Table 3 Random-effects summary estimates (as percentage change (95% CIs)) for mortality or hospital admissions associated with a 10 µg/m3 increase in air pollution
All
SC/MC*
Selected
SC/MC (cities)†
1 hour NO2 24-hour PM
Single-pollutant Adjusted for PM Single-pollutant Adjusted for NO2
All-cause mortality, all ages
PM10 2/1 2/1 (32) 0.22 (−0.15 to 0.60) 0.10 (−0.40 to 0.61) 0.52 (0.29 to 0.75) 0.48 (0.31 to 0.66)
BS 0/2 0/1 (30) 0.30 (0.22 to 0.38) 0.33 (0.23 to 0.43) 0.60 (0.30 to 0.90) 0.26 (0.00 to 0.52)
Visibility 0/1 0/1 (4) 0.63 (0.21 to 1.05) 0.52 (0.05 to 1.00) 35.70 (3.97 to 77.12)‡ 10.24 (−20.03 to 51.97)‡
All cardiovascular mortality, all ages
PM10 1/1 0/1 (29) 0.40 (0.29 to 0.51) 0.35 (0.21 to 0.49) 0.76 (0.47 to 1.05) 0.32 (0.05 to 0.59)
BS 1/1 0/1 (29) 0.40 (0.29 to 0.51) 0.44 (0.31 to 0.57) 0.62 (0.35 to 0.90) 0.17 (−0.10 to 0.44)
All respiratory mortality, all ages
PM10 0/1 0/1 (29) 0.38 (0.17 to 0.59) 0.37 (0.08 to 0.66) 0.71 (0.22 to 1.20) 0.20 (−0.29 to 0.69)
BS 0/1 0/1 (29) 0.38 (0.17 to 0.59) 0.26 (−0.12 to 0.64) 0.84 (0.11 to 1.58) 0.57 (−0.34 to 1.48)
All respiratory hospital admissions, children (<5 years)
PM10 1/1 1/1 (6) 0.77 (−0.59 to 2.15) 0.13 (−0.09 to 0.35) – –
PM2.5 0/1 0/1 (4) 1.62 (0.41 to 2.84) 4.85 (0.41 to 9.50) – –
All respiratory hospital admissions, elderly (65+years)
Visibility 0/1 0/1 (4) 1.42 (0.79 to 2.06) 1.21 (0.47 to 1.95) – –
Cardiac hospital admissions, elderly
Visibility 0/1 0/1 (4) 1.21 (0.84 to 1.58) 0.73 (0.31 to 1.16) – –
*Numbers of available pairs of single-city (SC)/multi-city (MC) estimates from all studies.
†Numbers of pairs of pooled (from single-city estimates) and multicity estimates used to calculate the overall summary estimate across WHO regions. Estimates were selected for meta-analysis
from all those available. The number of cities represented by the summary estimates is given in brackets.
‡The results for visibility (measured as black suspended particles (10−4/m)) are not comparable to other PM results.
BS, Black Smoke; NO2, nitrogen dioxide; PM, particulate matter.
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associations between various mass metrics of PM and all-
cause mortality. In the majority of studies, attenuation of
estimates was observed following control for 24-hour
NO2. Estimates for ultraﬁne particles and all-cause mor-
tality were robust to adjustment for 24-hour NO2 (see
online supplementary ﬁgure S11), but the data came
from three studies conducted in the same city—Erfurt,
Germany. Results of meta-analysis for all-cause mortality
and PM metrics are shown in tables 2 and 3 for adjust-
ment for 24-hour and 1 hour NO2, respectively. In con-
trast to the results for NO2, the summary estimates for
PM were attenuated, in most cases by more than half,
and CIs overlapped zero. Evidence of high heterogen-
eity between region-speciﬁc summary estimates for PM10
and all-cause mortality was identiﬁed (see online supple-
mentary table S6). Summary estimates for deaths from
all cardiovascular or all respiratory diseases and PM were
also sensitive to control for NO2 (see tables 2 and 3;
study estimates in online supplementary ﬁgures S12,
S13, tables S7 and S8 for region-speciﬁc results).
NO2 and hospital admissions
Few cause-speciﬁc and age-speciﬁc combinations of
hospital admissions for 24-hour or 1 hour NO2 with
control for PM had sufﬁcient numbers of estimates for
meta-analysis—all respiratory diseases in children and
the elderly, asthma in children, and cardiac disease in
all ages and the elderly—and half were based solely on a
multicity estimate from a single study.
Positive associations were identiﬁed between all
respiratory hospital admissions in different age groups
and 24-hour or 1 hour NO2, which remained after
control for PM (see tables 2 and 3; online supplemen-
tary ﬁgures S14 and S15 for available study estimates).
Evidence for the association between hospitalisation
for asthma in different ages and daily NO2 adjusted for
PM came from seven studies (see online supplementary
ﬁgures S16 and S17), six of which were conducted in
Europe. Sufﬁcient estimates for meta-analysis were only
available for asthma admissions in children and 24-hour
NO2 adjusted for any particles (measured as Black
Smoke, PM10 and PNC): a 2.81% (95% CI −1.28% to
7.06%) increase in risk per 10 µg/m3 24-hour NO2 was
attenuated following adjustment for particles (2.24%
(95% CI −1.12% to 5.71%)).
Five studies provided evidence for the relationship
between 24-hour NO2 adjusted for PM and hospitalisa-
tion for cardiac disease in all ages (see online supple-
mentary ﬁgure S18) and the elderly (see online
supplementary ﬁgure S19). Meta-analysis for the all age
Figure 2 All studies providing two-pollutant model estimates for all-cause mortality, all ages, PM adjusted for 24-hour NO2. PM,
particulate matter. PM, single-pollutant PM adjusted for NO2.
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category (table 2) identiﬁed positive estimates that were
attenuated and CIs overlapped zero after controlling for
PM10 and Black Smoke. One multicity study of four
Australian cities provided evidence for the relationship
between 1 hour NO2 and cardiac admissions in the
elderly. The association (1.21% (95% CI 0.84% to
1.58%)) was weakened by control for BSP (an indicator
of ﬁne particles), but remained statistically signiﬁcant
(0.73% (95% CI 0.31% to 1.16%)).
Sources of variation in NO2 estimates
We examined season-speciﬁc NO2 estimates of mortality
from studies that reported all-year estimates to explore
possible effect modiﬁcation by season. Some studies,
mainly from Western Europe, Canada and the USA,
reported stronger associations between daily mortality
and NO2 in the summer months (see online supplemen-
tary ﬁgures S20–S22). The extent of the correlations
between concentrations of NO2 and PM in the different
seasons is unclear because very few studies reported
these data, and only one study reported season-speciﬁc
estimates adjusted for PM. Similarly, limited evidence is
available on which to base an assessment of seasonal
variation of associations between hospitalisation for car-
diovascular and respiratory diseases and 24-hour NO2
(see online supplementary ﬁgure S23).
We explored reasons for the observed high heterogen-
eity by ranking study estimates for all-cause mortality and
24-hour NO2 (from the full data set)
12 by different poten-
tial effect modiﬁers (see online supplementary ﬁgures
S24–S27). None of the variables used to represent the
pollution and meteorological environments in the cities
examined accounted for the observed between-study
variability.
DISCUSSION
Sixty time-series studies of NO2 were used to determine
whether NO2 is associated with daily mortality or hos-
pital admissions independently of daily PM. In general,
our results demonstrate that after controlling for PM,
daily NO2 remained signiﬁcantly associated with
increases in the risk of adverse health outcomes. The
evidence appears clearest for daily deaths from all
causes and from all cardiovascular and all respiratory
diseases, and for all respiratory hospital admissions, out-
comes for which more co-pollutant estimates were avail-
able. Robustness of the NO2 associations to control for
PM was observed at both high and low correlations
between NO2 and PM, and no clear relationship could
be discerned between the correlations and changes in
the size of the adjusted NO2 estimates. In contrast to the
results for NO2, the associations between daily PM and
the main mortality outcomes (all cause, all cardiovascu-
lar, all respiratory) were very sensitive to the inclusion of
NO2 in two-pollutant models.
Two/multipollutant models are increasingly being
used to draw conclusions about whether or not NO2 is
independently associated with adverse health outcomes.
This comprehensive review provides systematic evalu-
ation and formal meta-analysis of the full body of two-
pollutant estimates of NO2 adjusted for PM, across
several cause-speciﬁc and age-speciﬁc health outcomes,
both globally and by different geographical regions.
While earlier reviews7–8 13 20–23 included some assess-
ment of these data, they were either limited in scope to
speciﬁc health outcomes, and/or examined two-
pollutant and multipollutant model NO2 estimates
together, or did not undertake meta-analysis whatsoever.
Another key strength of this review is the protocol-led
approach to identifying and assembling studies and esti-
mates, which aimed to minimise selection bias in the dif-
ferent stages of the review.
The subset of studies of NO2 analysed in this paper
were generally comparable to the studies examined in
our earlier paper in terms of the magnitudes of
summary estimates and overlap in CIs.12 For example,
the single-pollutant summary estimates for all-cause
mortality, the outcome with the most data, were
similar across both data sets, suggesting that the
studies reporting two-pollutant model estimates
were typical of the wider body of time-series evidence
of NO2.
While evidence of NO2 associations which are robust
to control for PM mass has been identiﬁed, it is possible
that there may be some residual confounding by PM.
The components of PM—primary combustion particles,
for example, ultraﬁne particles or Black Carbon—which
have been proposed as the real causal agents of the NO2
associations, were not included in co-pollutant models
of NO2 because concentration data for these pollutants
were either unavailable or sparse, reﬂecting the fact that
these PM metrics are not routinely measured. PM10 was
by far the most used metric— in 67% of the studies.
Summary estimates of NO2 were generally robust to
adjustment for PM10. However, PM10 may not adequately
reﬂect the toxic component of PM because it reﬂects a
number of sources that do not include combustion/
trafﬁc and that, are not shared with NO2. Where the
data permitted meta-analysis, robustness of the NO2
associations to adjustment for PM2.5 and Black Smoke
was observed. Few data were available to permit an
assessment of the extent to which the NO2 associations
are sensitive to control for combustion-derived particles
such as Black Carbon or ultraﬁne particles. This has also
been noted by others.7–8 24
Given that the sources and composition of PM vary by
location, and hence its toxicity, it cannot be assumed
that PM represents the same thing in each study (city/
country). In view of the differential toxicity of PM, it is
preferable to examine individual studies that used more
than one particle metric to investigate possible con-
founding of the NO2 associations by PM when answering
the research question, because they ‘tested’ the robust-
ness of the NO2 associations to different fractions/com-
ponents of the ambient aerosol in the same location.
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Unfortunately, such studies were few in number (8), but
their ﬁndings support the view that the associations of
NO2 with major health outcomes are robust to adjust-
ment for PM measured in different ways.
We observed confounding of the associations between
daily PM and mortality outcomes by NO2. This suggests
that NO2, rather than the PM metrics examined, is a
better predictor of the observed mortality effects in the
cities examined. An alternative interpretation may be
that daily variation in NO2 in the cities better represents
the mortality effects of daily variations in the complex
urban air pollution mixture or an unknown toxic entity
than the metrics of PM used in the analyses. Some
caution is, however, needed in drawing conclusions
about the analysis of PM estimates because it only
reﬂects a subset of the available studies on PM. Whether
the results are a feature of the subset of studies exam-
ined is unclear, and formal meta-analysis of the full body
of PM estimates, similar to the current review, is war-
ranted. This may provide further insights into whether
the different fractions/components of PM might show
different sensitivity to adjustment for NO2.
Our results for PM are in contrast with the predomin-
ant views in the literature: although confounding of the
PM-mortality associations by NO2 has been observed in
some time-series studies25–27 and noted in reviews,6 the
general consensus is that the PM-mortality estimates are
robust to adjustment for co-pollutants.6 The associations
have been regarded as reﬂecting a causal relationship,
and experimental evidence has been used to support
this. There is a lack of experimental evidence for NO2 at
current ambient concentrations and for cardiovascular
endpoints, and this has contributed to uncertainty
regarding whether NO2 is causally related to health.
We also found evidence of high heterogeneity between
the geographic speciﬁc summary estimates of NO2, which
suggests that it cannot be assumed that the results for one
city (region) represent the results for all cities (regions).
For all-cause mortality and 24-hour NO2, the high hetero-
geneity between WHO region-speciﬁc estimates was com-
pletely removed after control for PM (I2 from 66.9% to
0%), suggesting that some study estimates were a bit
extreme in comparison with others in the meta-analysis,
but were less so after adjustment for PM. Geographical
variation in effect estimates may be due to variations in
population characteristics and in pollution sources, mix-
tures and ambient concentrations. However, none of the
variables used to represent the pollution and meteoro-
logical environments in the cities examined accounted
for the high between-study variability we observed.
Further work is therefore required to investigate potential
explanations for the heterogeneity.
Results from the studies published since our literature
search cut-off are summarised and discussed in the online
supplementary appendix 1. The studies indicate that, in
general, the associations between NO2 and mortality and
hospital admissions remain after control for PM. This is in
keeping with the ﬁndings set out in this paper.
In addition to the issue of confounding, studies have
examined the potential for factors (eg, season, socio-
economic status, age, etc) to modify the relationship
between daily NO2 and mortality or hospital admissions.
Few studies have, however, examined modiﬁcation of the
associations of NO2 with health by particulate air pollu-
tion. The available evidence suggests that the size of an
NO2 association may be dependent on concentrations of
PM10.
25 However, studies have also observed the poten-
tial for daily NO2 to modify the relationship between
PM and mortality.28 The few available data on this issue
come largely from the USA and Europe, but interaction
between NO2 and PM (on cardiac hospitalisation) has
also been observed in Hong Kong.29 Further research
on this aspect of the NO2–PM issue is needed.
Our review supports the conclusions of recent narrative
reviews,7 8 but also provides meta-analytical estimates based
on two-pollutant model estimates of NO2 from the world-
wide data. Taken together with the recent quantitative
reviews of cohort studies on long-term exposure to NO2
and mortality,30 31 and of short-term exposure to NO2 and
respiratory symptoms in children with asthma from panel
studies,8 32 the evidence suggests a need for re-evaluation
of the approach to health risk assessment (hazard identiﬁ-
cation and health impact assessment) for air pollution, an
activity that has long been dominated by PM.33 The
current review suggests that the relationship between tem-
poral variations in PM and mortality may not be as robust
to control for NO2 as previously thought. We note also that
attenuation of PM–mortality estimates following control
for NO2 has been observed in long-term exposure
studies.34 35 These ﬁndings could have implications for the
calculation of health impacts attributable to these pollu-
tants and for possible double counting of effects.
In summary, we identiﬁed evidence of associations
between NO2 and adverse health outcomes that are
independent of PM mass. However, there was limited evi-
dence on adjustment of the NO2 associations for
primary combustion particles that are thought to be
responsible for the NO2 associations. Therefore, some
uncertainty remains regarding possible confounding
and health impact assessments should reﬂect this.
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